Blue Jet Healthcare Q4 Results: Stock gains 10% despite weak earnings; Board approves fund raise

For the March quarter, Blue Jet Healthcare’s Earnings Before Interest, Tax, Depreciation and Amortisation (EBITDA) fell 49% to ₹71 crore from ₹140 crore a year ago, while EBITDA margin contracted sharply to 30.3% from 41%. Yet, the stock was up 10%.